Pharmosa Biopharm Inc.

NT$25.30As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6875Healthcare
Country Taiwan
PE (Fwd) •••
TSR 5Y CAGR (11.01%)
Div yield —
ROE (22.83%)
Biotechnology
Beta (5Y) 0.26
PE TTM —
TSR TTM (50.87%)
Mkt cap NT$3.268B
ROIC (14.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$31
21.29%
(71.68%)
Hold 10|11|10|5|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.37
0.37
0.36
0.37
(5.84%)
(5.78%)
(8.00%)
0.19%
RevenueNT$M
154.2
155.0
153.1
159.1
0.02%
1.12%
2.16%
5.06%
Peers (US$98.71M)
Cap (US$)
PE
102.2M
10.25x
Capital
TTM
5Y
10Y
Leveragex
1.043
0.258
0.293
EBIT/Intx
4.991
0.180
0.151
Own earn%
68.73
27.32
43.44
Sh yield%
23.27
36.42
37.09
Owners
Insiders/Inst%
9.95
58.57
Short interest%
4.16
SBC / revenue%
0.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
12–20
$1 testx
0.1
Incr. ROIC%
7